Enhancement of the Soluble Form of OX40 and OX40L Costimulatory Molecules but Reduction of the Membrane Form in Type 1 Diabetes (T1D)
This study analyzed the expression of membrane OX40 and OX40L (mOX40 and mOX40L) and levels of soluble OX40 and OX40L (sOX40 and sOX40L) in T1D patients to determine their clinical significance. Peripheral blood (PB) was collected from patients with T1D and healthy control participants. Expression o...
Saved in:
| Main Authors: | Jingnan An, Sisi Ding, Sicheng Li, Lili Sun, Xin Chang, Ziyi Huang, Bin Zhou, Chen Fang, Cuiping Liu, Xueguang Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2019/1780567 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Significance of OX40 and OX40 Ligand in the Peripheral Blood of Patients with Myasthenia Gravis
by: Xiaoling Zhou, et al.
Published: (2022-01-01) -
Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia
by: Dawei Cui, et al.
Published: (2019-01-01) -
OX40/OX40L as a Therapeutic Target in Atopic Dermatitis: A Scoping Review
by: Valenzuela F, et al.
Published: (2025-05-01) -
OX40–OX40L Axis in Cutaneous T-Cell Lymphomas: Pathogenic, Prognostic, and Potential Therapeutic Perspectives
by: Alba Guglielmo, et al.
Published: (2025-05-01) -
A Narrative Review of the OX40-OX40L Pathway as a Potential Therapeutic Target in Atopic Dermatitis: Focus on Rocatinlimab and Amlitelimab
by: Asaad Abdelhalim, et al.
Published: (2024-11-01)